This inventor holds 1 USPTO granted patent. Top assignee: Imperial Chemical Industries Limited. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: The Innovative Contributions of Linda Salter
Introduction
Linda Salter is a notable inventor based in Macclesfield, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that have therapeutic applications. Her work focuses on addressing critical health issues, such as diabetes and galactosemia.
Latest Patents
Linda Salter holds a patent for her invention related to acetamide derivatives. The patent describes novel N-phenylacetyl and related acyl derivatives of (4-amino-2,6-dimethylphenylsulphonyl)nitromethane and pharmaceutically acceptable salts thereof. These compounds serve as inhibitors of the enzyme aldose reductase, which is valuable in treating certain peripheral effects of diabetes and galactosemia. The patent also includes pharmaceutical compositions containing these derivatives and outlines processes for their manufacture and use.
Career Highlights
Throughout her career, Linda has been associated with Imperial Chemical Industries Limited, where she has contributed to various innovative projects. Her expertise in pharmaceutical chemistry has enabled her to develop compounds that have the potential to improve patient outcomes in critical health conditions.
Collaborations
Linda has collaborated with esteemed colleagues, including David R Brittain and Steven P Brown. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Linda Salter's innovative work in the field of pharmaceuticals exemplifies the impact of dedicated inventors on healthcare. Her contributions, particularly in the development of acetamide derivatives, highlight the importance of innovation in addressing significant medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
